Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Gilead Sciences 7.803, Henry Schein 3.458.
Gilead Sciences vs Henry Schein Net Worth and Market Cap
Gilead Sciences (GILD) and Henry Schein (HSIC) are peers in Healthcare. Gilead Sciences reported revenue of $7.8B as of Q2 2026, compared with $3.5B for Henry Schein. Gilead Sciences leads on revenue.
Gilead Sciences's gross margin is 79.8% versus 31.8% for Henry Schein. Gilead Sciences's net margin is -134.5% versus 2.7% for Henry Schein.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Gilead Sciences, Henry Schein.| Metric | Gilead Sciences | Henry Schein |
|---|---|---|
| Market Cap | - | - |
| Revenue | $7.80B | $3.46B |
| Cost of Revenue | $1.58B | $2.36B |
| Gross Profit | $6.22B | $1.10B |
| Operating Income | $-10.39B | $200.00M |
| Net Income | $-10.50B | $94.00M |
| R&D Expense | $1.76B | $0 |
| Earnings Per Share | -$8.45 | $0.82 |
| Gross Margin | 79.8% | 31.8% |
| Operating Margin | -133.2% | 5.8% |
| Net Profit Margin | -134.5% | 2.7% |
| Free Cash Flow | $3.69B | $196.00M |
| Cumulative Free Cash Flow | $155.83B | $9.89B |
| Operating Cash Flow | $3.57B | $242.00M |
| Cash & Equivalents | $3.18B | $157.00M |